Skip to content
Triangle logo TriangleGet started
← Full study record

NCT03500419 · OUTCOME

Erectogenic Therapy Use

Penile Length Maintenance Post-Prostatectomy · Source last updated 2021-10-20

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

Measure
NUMBER
Unit
percentage of subjects
Interval / dispersion
Not reported
Time frame
6 months

What was measured

The percentage of subjects to use a phosphodiesterase-5 inhibitor for erectogenic therapy use

Analysis population: 6 months data was not collected nor analyzed for 2 subjects in control arm and 25 subjects in PTT arm.

Groups in this outcome

Control

No treatment was administered for the initial 6 months post-prostatectomy. This is necessary as a measure to review post-prostatectomy penile length changes. No treatment: Control group. No treatment was given for the 6 months post-prostatectomy

PTT 1-2x Daily x 5-7 Days/Week x 5 Months

Men utilized penile traction therapy for 30 minutes 1-2 times daily, 5-7 times a week, beginning 4 weeks post-prostatectomy for a period of 5 months. RestoreX: PTT - Penile traction therapy in the straight position.

Group identifiers and denominators belong to this outcome only. They may differ in another outcome or in safety reporting.

Analysis denominator · Participants

GroupSource count
Control25
PTT 1-2x Daily x 5-7 Days/Week x 5 Months30

Reported measurements

Source class 1
Values in percentage of subjects · Interval/dispersion: Not reported
GroupValueSpreadLowerUpperComment
Control94Not reportedNot reportedNot reportedNot reported
PTT 1-2x Daily x 5-7 Days/Week x 5 Months86Not reportedNot reportedNot reportedNot reported
Complete source fields
classes
  1. categories
    1. measurements
      1. group Id
        OG000
        value
        94
      2. group Id
        OG001
        value
        86
denoms
  1. counts
    1. group Id
      OG000
      value
      25
    2. group Id
      OG001
      value
      30
    units
    Participants
description
The percentage of subjects to use a phosphodiesterase-5 inhibitor for erectogenic therapy use
groups
  1. description
    No treatment was administered for the initial 6 months post-prostatectomy. This is necessary as a measure to review post-prostatectomy penile length changes. No treatment: Control group. No treatment was given for the 6 months post-prostatectomy
    id
    OG000
    title
    Control
  2. description
    Men utilized penile traction therapy for 30 minutes 1-2 times daily, 5-7 times a week, beginning 4 weeks post-prostatectomy for a period of 5 months. RestoreX: PTT - Penile traction therapy in the straight position.
    id
    OG001
    title
    PTT 1-2x Daily x 5-7 Days/Week x 5 Months
param Type
NUMBER
population Description
6 months data was not collected nor analyzed for 2 subjects in control arm and 25 subjects in PTT arm.
reporting Status
POSTED
time Frame
6 months
title
Erectogenic Therapy Use
type
SECONDARY
unit Of Measure
percentage of subjects

Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f

Preserved source evidence · Not medical advice